Nuclear Medicine Software Market to Reach USD 1,803.9 Million by 2032 Amid Rising Incidence of Chronic Diseases
Burlingame, CA, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The Global Nuclear Medicine Software Market is estimated to be valued at USD 980.5 Mn in 2025 and is expected to reach USD 1,803.9 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032. A key trend in the nuclear medicine software market is the adoption of artificial intelligence and machine learning, enhancing image analysis precision and streamlining workflows. Growing incidences of chronic diseases and cancer are boosting demand for accurate diagnostic solutions, further propelling market growth. The shift toward cloud-based platforms and seamless integration with hospital systems is also gaining momentum, supporting real-time data access and improved patient care. Together, these advancements are driving the market toward more efficient and scalable software solutions.
Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/8470
Global Nuclear Medicine Software Market Key Takeaways
According to Coherent Market Insights (CMI), the global nuclear medicine software market size is expected to grow at a CAGR of 9.1% during the forecast period, totaling USD 1,803.9 Mn by 2032, up from USD 980.5 Mn in 2025.
Patient data management software is slated to remain a highly sought-after type, accounting for a market share of 28.1% in 2025.
By modality, Positron Emission Tomography (PET) segment is set to account for 37.8% of the global nuclear medicine software market share by 2025.
Based on therapeutic area, oncology category is projected to dominate the industry, capturing 34.5% of the global market in 2025.
North America is expected to account for nearly 2/5 of the global nuclear medicine software industry share by 2025.
Asia Pacific is poised to emerge as one of the most lucrative markets for nuclear medicine software companies during the assessment period.
Increasing Prevalence of Chronic Diseases Fueling Market Growth
Coherent Market Insights’ latest nuclear medicine software market analysis outlines key factors driving industry growth. One such prominent growth factor is the rising prevalence of chronic diseases.
The global burden of chronic conditions like cancer and cardiovascular diseases is rising rapidly. For instance, the World Health Organization (WHO) estimates annual number of new cancer cases to surpass 35 million by 2050. This alarming rise is expected to boost growth of the nuclear medicine software.
Nuclear medicine plays a vital role in early detection, diagnosis, and treatment of these chronic diseases. Its growing adoption to address chronic disease burden will, therefore, fuel demand for nuclear medicine software.
High Implementation Costs Limiting Market Growth
The global nuclear medicine software market outlook looks bright, owing to rising prevalence of chronic diseases and growing demand for advanced diagnostic tools. However, high cost of nuclear medicine software is a significant challenge to market expansion.
Small healthcare centers, especially in underserved areas, struggle to afford nuclear medicine software because it is expensive. This may slow down the growth of the nuclear medicine software market during the forecast period.
Advancements in Imaging Technologies Creating New Opportunities
Technological innovations in imaging modalities like Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) are enhancing diagnostic capabilities. These advancements necessitate cutting-edge software for image processing as well as analysis, opening revenue streams for nuclear medicine software providers.
Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/8470
Impact of AI on the Nuclear Medicine Software Market
Artificial Intelligence (AI) is turning out to be a powerful tool in the nuclear medicine software market. It is being increasingly used in nuclear medicine software platforms to address various challenges faced by healthcare professionals.
AI-powered algorithms have the tendency to enhance image reconstruction, automate data analysis, and improve diagnostic accuracy. They enable faster and more precise detection of conditions like cancer and cardiovascular diseases.
AI-powered predictive analytics help healthcare providers work more efficiently, reduce mistakes, and create personalized treatment plans. Because of this, more healthcare providers are using AI-based nuclear medicine software.
Leading companies are launching new AI-based solutions to capitalize on emerging opportunities. For instance, GE Healthcare recently introduced an enhanced version of its LesionID Pro at the SNMMI.
The new software automatically processes PET and SPECT images without any manual steps. It helps simplify the analysis of whole-body tumor burden by reducing the need for manual image segmentation as well as alignment.
Emerging Nuclear Medicine Software Market Trends
Shift toward personalized medicine is a key growth-shaping trend in the nuclear medicine software market. More attention is being given to treatments tailored to each patient, and nuclear medicine software plays a key role in customizing these therapies. This makes treatments more effective as well as improves patient outcomes, which increases demand for advanced software tools.
Another notable trend is the usage of artificial intelligence technology. Companies are increasingly incorporating AI and ML algorithms into nuclear medicine software to improve image analysis and operational efficiency.
Cloud-based nuclear medicine software solutions are gaining popularity, thanks to their scalability, accessibility, and cost-effectiveness. Their rising adoption, especially among hospitals and clinics with limited budgets and infrastructure, is expected to boost market growth.
The growing use of theranostics is significantly boosting the nuclear medicine software market. Theranostics, an integrative approach that merges advanced diagnostic imaging with precision-targeted radiopharmaceutical therapy, is transforming the landscape of personalized medicine, especially in oncology. This trend is increasing the demand for advanced nuclear medicine software that helps with imaging, dosimetry, and treatment planning.
The subscription-based model is gaining traction in the nuclear medicine software market. This is due to its lower capital expenditure for healthcare providers and its ability to provide continuous updates and support.
Get Customization on this Report: https://www.coherentmarketinsights.com/insight/request-customization/8470
Analyst’s View
“The global nuclear medicine software industry is set to record rapid growth, owing to rising prevalence of chronic diseases, surging demand for advanced diagnostic technologies, and continuous advancements in nuclear medicine software,” said a senior CMI analyst.
Current Events and Their Impact on the Nuclear Medicine Software Market
| Event | Description and Impact |
| Surge in AI/ML-Based Medical Device Approvals (2024–2025) |
|
| Pharmaceutical Investments in Radiopharmaceuticals (2024–2025) |
|
| Cybersecurity Regulations and Healthcare Data Protection |
|
Competitor Insights
Key companies in the nuclear medicine software market report:
- GE HealthCare
- Siemens Healthineers
- Philips Healthcare
- Canon Medical Systems Corporation
- Hermes Medical Solutions AB
- Bracco Imaging S.p.A.
- Segami Corporation
- MIM Software Inc.
- INVIA Medical Imaging Solutions
- Mirada Medical Ltd.
- PMOD Technologies LLC
- Nuclear Diagnostics AB
- Sofie Biosciences Inc.
- Xeleris
- Mediso Medical Imaging Systems
Key Developments
In June 2025, GE HealthCare enhanced its precision care by launching the new MIM Encore software. This novel software is designed to solve healthcare challenges by boosting efficiency, cutting down manual work, and improving communication.
In May 2025, Hermes Medical Solutions released new updates to its Hermia software suite. These novel innovations are designed to advance precision and efficiency in nuclear medicine imaging and dosimetry.
In December 2024, Royal Philips unveiled its newest AI-powered imaging tools for diagnosis and treatment at the RSNA 2024 conference. These tools aim to improve precision imaging by making workflows faster, simpler, and more efficient. They are designed to help radiologists overcome different challenges.
Market Segmentation
-
Type Insights (Revenue, USD Mn, 2020 - 2032)
- Patient Data Management Software
- Imaging and Visualization Software
- Analysis and Quantification Software
- Clinical Decision Support Software
- Dosimetry Software
- Workflow and Scheduling Software
- Treatment Planning Software
- Others (Artificial Intelligence (AI) and Analytics Software, etc.)
-
Modality Insights (Revenue, USD Mn, 2020 - 2032)
- Positron Emission Tomography (PET)
- Single Photon Emission Computed Tomography (SPECT)
- Hybrid Imaging Software (PET/CT, SPECT/CT, PET/MRI)
- Others (Planar Scintigraphy, hybrid systems)
-
Therapeutic Area Insights (Revenue, USD Mn, 2020 - 2032)
- Oncology
- Cardiology
- Neurology
- Endocrinology
- Gastroenterology
- Others (Orthopedics, Infectious disease imaging, etc.)
-
Deployment Model Insights (Revenue, USD Mn, 2020 - 2032)
- On-Premise
- Cloud-Based
-
Integration Complexity Insights (Revenue, USD Mn, 2020 - 2032)
- Standalone Software
- Integrated Software Solutions
-
Pricing Model Insights (Revenue, USD Mn, 2020 - 2032)
- Subscription-based Pricing
- Perpetual License Pricing
- Usage-based Pricing (pay-per-use)
- Freemium or Trial-based Pricing
- Customized or Enterprise Pricing
-
End User Insights (Revenue, USD Mn, 2020 - 2032)
- Hospitals and Clinics
- Diagnostic Imaging Centers
- Academic and Research Institutions
- Pharmaceutical and Biotechnology Companies
-
Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- North America
Read Report:
Nuclear Imaging Equipment Market Size, Share, Trends & Opportunities for 2025-2032
Radiopharmaceuticals in Nuclear Medicine Market Size, Share & Trends Analysis Report (2025-2032)
Nuclear Medicine Market Size, Share, Trends & Opportunities for 2025-2032
About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries. Contact Us: Mr. Shah Coherent Market Insights 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States US: + 12524771362 UK: +442039578553 AUS: +61-2-4786-0457 India: +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com For Latest Update Follow Us: LinkedIn | Facebook | Twitter
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
